# COVID-19 and Cancer Consortium Registry

> **NCT04354701** · — · ACTIVE_NOT_RECRUITING · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 19275 (actual)

## Conditions studied

- COVID-19
- Invasive Malignancy (Any Type)

## Interventions

- **OTHER:** Web-based REDCap survey

## Key facts

- **NCT ID:** NCT04354701
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-17
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 19275 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354701, "COVID-19 and Cancer Consortium Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04354701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*